Cargando…
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study
BACKGROUND: Deimplementation, the removal or reduction of potentially hazardous approaches to care, is key to progressing social equity in health. While the benefits of opioid agonist treatment (OAT) are well-evidenced, wide variability in the provision of treatment attenuates positive outcomes. Dur...
Autores principales: | Conway, Anna, Marshall, Alison D., Crawford, Sione, Hayllar, Jeremy, Grebely, Jason, Treloar, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250852/ https://www.ncbi.nlm.nih.gov/pubmed/37296448 http://dx.doi.org/10.1186/s13012-023-01281-4 |
Ejemplares similares
-
“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
por: Conway, Anna, et al.
Publicado: (2023) -
People engaged in opioid agonist treatment as a counterpublic during the COVID‐19 pandemic in Australia: A qualitative study
por: Conway, Anna, et al.
Publicado: (2022) -
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study
por: Conway, Anna, et al.
Publicado: (2022) -
Behavioral and Psychological Aspects of the Physician Experience with Deimplementation
por: McDaniel, Corrie E., et al.
Publicado: (2022) -
Unwinding old habits: deimplementation of treatment regimens for patent ductus arteriosus in preterm infants()()
por: Benitz, William E.
Publicado: (2018)